Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Otolaryngeal Cancer × Ketamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Anxiety Disorders 3 Pain 2 Gastrointestinal Neoplasms 2 Depression 2 Acute Pain 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain, Postoperative 1 Otolaryngeal Cancer 1 Mucositis 1 Lymphoma, Follicular 1 Head and Neck Neoplasms 1 Fatigue 1 Colorectal Neoplasms 1 Cancer: Breakthrough Pain 1

Interventions

Saline Solution 1 Ketamine 1 Electroencephalography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03040024 2021-07-08

Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients

Emory University

Phase 4 Terminated

71 enrolled 17 charts

Otolaryngeal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡